<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Korean J Pediatr</journal-id><journal-id journal-id-type="publisher-id">KJP</journal-id><journal-title-group><journal-title>Korean Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">1738-1061</issn><issn pub-type="epub">2092-7258</issn><publisher><publisher-name>The Korean Pediatric Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29853940</article-id><article-id pub-id-type="pmc">5976565</article-id><article-id pub-id-type="doi">10.3345/kjp.2018.61.5.156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2472-6813</contrib-id><name><surname>Fahmey</surname><given-names>Sameh Samir</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1-kjped-61-156">1</xref></contrib><contrib contrib-type="author"><name><surname>Mostafa</surname><given-names>Heba</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1-kjped-61-156">1</xref></contrib><contrib contrib-type="author"><name><surname>Elhafeez</surname><given-names>Noha Abd</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2-kjped-61-156">2</xref></contrib><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Heba</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1-kjped-61-156">1</xref></contrib></contrib-group><aff id="A1-kjped-61-156"><label>1</label>Pediatrics Department, Beni-Suef University, Beni Suef, <country>Egypt</country>.</aff><aff id="A2-kjped-61-156"><label>2</label>Clinical and Chemical Pathology Department, Beni-Suef University, Beni Suef, <country>Egypt</country>.</aff><author-notes><corresp>Corresponding author: Sameh Samir Fahmey, MD. Pediatrics Department, Beni-Suef University, Beni Suef, Egypt. Tel: +20-1289732856, Fax: +20-227539322, <email>ssfahmey34@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2018</year></pub-date><volume>61</volume><issue>5</issue><fpage>156</fpage><lpage>159</lpage><history><date date-type="received"><day>25</day><month>11</month><year>2017</year></date><date date-type="rev-recd"><day>13</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2018 by The Korean Pediatric Society</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>The Korean Pediatric Society</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Sepsis is a major cause of neonatal morbidity and mortality. Early diagnosis is a major problem because of the lack of specific clinical signs. Therefore, a reliable diagnostic marker is needed to guide the use of antimicrobial agents. The objective of our study was to assess the value of proadrenomedullin (pro-ADM) in establishing the diagnosis and evaluating the prognosis of neonatal sepsis.</p></sec><sec><title>Methods</title><p>This study enrolled 60 newborn infants with sepsis proven with positive blood cultures and 30 healthy neonates. Complete blood count, C-reactive protein levels, and pro-ADM levels were obtained from all neonates.</p></sec><sec><title>Results</title><p>The pro-ADM levels were significantly higher (14.39&#xB1;0.75 nmol/L) in the sepsis group than in the control group (3.12&#xB1;0.23 nmol/L). The optimal cutoff value for pro-ADM was 4.3 nmol/L, with a sensitivity of 93.3% and a specificity of 86.7%. The pro-ADM levels were also higher in nonsurvivors (<italic>P</italic>=0.001).</p></sec><sec><title>Conclusion</title><p>Pro-ADM can be used as a reliable biomarker for neonatal sepsis. High pro-ADM levels were associated with mortality and could be an early indicator of disease outcome.</p></sec></abstract><kwd-group><kwd>Neonate</kwd><kwd>Proadrenomedullin</kwd><kwd>Sepsis</kwd><kwd>Marker</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Sepsis is one of the major causes of death during neonatal period. Despite recent advances in treatment of neonatal infection, mortality and comorbidities remain high.<xref rid="B1-kjped-61-156" ref-type="bibr">1)</xref></p><p>Early and accurate diagnosis of neonatal sepsis represent important challenge for neonatologists as clinical signs are difficult to differentiate from other noninfective neonatal conditions. Although blood culture is the gold standard for diagnosis, its result takes too long time.<xref rid="B2-kjped-61-156" ref-type="bibr">2)</xref> False negative results are common because of low-level bacteremia, and the small volume of blood sample. Moreover, the early administration of antibiotic before withdrawn of blood culture significantly reduce its diagnostic accuracy.<xref rid="B3-kjped-61-156" ref-type="bibr">3)</xref></p><p>Early diagnosis of neonatal sepsis is crucial to avoid clinical deterioration, reduce mortality and prevent unnecessary use of antimicrobial agents. Also, accurate diagnosis will decrease the incidence of antibiotic resistance and reduce treatment-related cost.<xref rid="B4-kjped-61-156" ref-type="bibr">4)</xref></p><p>Adrenomedullin (ADM) consists of 52-amino acid and possesses vasodilator and natriuretic properties. ADM could be used as a biomarker for cardiovascular diseases and infection.<xref rid="B5-kjped-61-156" ref-type="bibr">5)</xref></p><p>However, reliable measurement of ADM in the circulation is very difficult because of its very short plasma half-life (about 22 minutes). Midregional pro-ADM (MR-proADM) is a fragment of ADM precursor (amino acids 45 to 92) and is more stable than the rapidly cleared ADM. MR-proADM is easy to measure and reliably reflects the amount of released ADM.<xref rid="B6-kjped-61-156" ref-type="bibr">6)</xref></p><p>The aim of our study was to assess the value of pro-ADM in establishing the diagnosis and evaluating the prognosis of neonatal sepsis.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>This prospective study was conducted at the Neonatal Intensive Care Unit of Beni Suef University Hospital in the period between May 2016 and January 2017. Sixty neonates fulfilling the criteria for diagnosis of septicemia were included in our study (sepsis group). The control group included 30 healthy neonates, they were recruited from follow-up clinic for healthy neonate.</p><p>Patients with cardiac failure, maternal preeclampsia, or intracranial hemorrhage (Conditions in which plasma pro-ADM have been reported to be elevated) were excluded from the study.</p><p>Sepsis was defined as a positive blood culture in infants with clinical and laboratory findings of infection. Manifestations of sepsis include poor suckling, sleepiness, respiratory distress, apnea, poor perfusion, cyanosis, bradycardia, fever or hypothermia, feeding intolerance, and neurological signs (as seizures).<xref rid="B7-kjped-61-156" ref-type="bibr">7)</xref></p><p>Routine sepsis evaluations included complete blood count, C-reactive protein, and blood culture. Blood was drawn from all neonates for Pro-ADM assay.</p><sec><title>1. Sample collection and Pro-ADM assay</title><p>Blood samples were taken from septic neonates after confirmation by positive blood culture. Blood samples were collected under standardized conditions in plasma collection tubes containing ethylenediaminetetraacetic acid. Then, samples were centrifuged at 1,000&#xD7;g (2&#x2103;&#x2013;8&#x2103;) for 15 minutes within half an hour of collection then plasma samples are stored at &#x2212;20&#x2103;. Samples are centrifuged again after thawing before the assay.</p><p>The assay applies the quantitative sandwich enzyme immunoassay technique using Human Pro-ADM ELISA Kit (Cusabio Biotech Co., Ltd., Wuhan, China).</p><p>The study protocol was approved by Beni Suef University Hospital ethical committee (approval number: 187-16), and written informed consent was obtained from caregivers.</p></sec><sec><title>2. Statistical analysis</title><p>Data management and analysis were performed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA).</p><p>Data were described as mean&#xB1;standard deviation or frequencies and percentages when appropriate. Comparisons between cases and controls were done using the <italic>t</italic> tests. We used Mann-Whitney test to compare 2 unrelated samples. To measure the strength of the association between pro-ADM and other parameter, Pearson correlation coefficients were used. The Receiver operator characteristic (ROC) curve was used to demonstrate the relationship between sensitivity and specificity.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Our study included 90 neonates (60 septic neonates and 30 healthy controls). Their clinical and laboratory characteristics are summarized in <xref ref-type="table" rid="T1-kjped-61-156">Table 1</xref>. Septic neonates had a lower weight compared with neonates in the control group. Pro-ADM concentrations were significantly higher (<italic>P</italic>&lt;0.001) in the septic group (14.39&#xB1;0.75 nmol/L) compared with control group (3.12&#xB1;0.23 nmol/L).</p><p>The pathogens detected in blood cultures of septic neonates are listed in <xref ref-type="table" rid="T2-kjped-61-156">Table 2</xref>. <italic>Klebsiella pneumoniae</italic> was the most frequent organism isolated.</p><p>Eleven neonates (18.3%) received mechanical ventilation, 8 neonates (13.3%) received continuous positive airway pressure, total parenteral nutrition was given to 12 septic neonates (20%) and central venous catheters were required in 14 neonates (23.3%).</p><p>Of the 60 septic infants that were included in the study, 12 neonates (20%) died while 48 neonates (80%) recovered and discharged. The mean pro-ADM levels in survivors and nonsurvivors were 14.21&#xB1;0.72 nmol/L and 15.08&#xB1;0.27 nmol/L, respectively (<xref ref-type="fig" rid="F1-kjped-61-156">Fig. 1</xref>). Pro-ADM levels were significantly higher in patients who died with a <italic>P</italic> value=0.001.</p><p>The area under the receiver-operating curve for pro-ADM was 0.923 (95% confidence interval [CI], 0.85&#x2013;0.97) (<xref ref-type="fig" rid="F2-kjped-61-156">Fig. 2</xref>). A pro-ADM value of 4.3 nmol/L was established as a cutoff value with 93.3% (95% CI, 78&#x2013;99) sensitivity and 86.7% (95% CI, 59&#x2013;98) specificity. The positive and negative predictive values were 93.3% (95% CI, 85&#x2013;97) and 86.6% (95% CI, 71&#x2013;94), respectively.</p><p>As shown in <xref ref-type="table" rid="T3-kjped-61-156">Table 3</xref>, the levels of pro-ADM were positively correlated with weight (<italic>r</italic>=0.36, <italic>P</italic>=0.013) and CRP (<italic>r</italic>=0.662, <italic>P</italic>&lt;0. 001). However, pro-ADM levels tended to correlate negatively with platelets count (<italic>r</italic>=&#x2212;0.714, <italic>P</italic>&lt;0.001) and hemoglobin (<italic>r</italic>=&#x2212;0.62, <italic>P</italic>&lt;0.001).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Neonatal sepsis is a major health challenge in neonatal intensive care units and has a fulminant and fatal course if treatment is not initiated rapidly. The identification of reliable and accurate biomarkers for sepsis could guide treatment, reduce overuse of antimicrobial agents, and possibly improve prognosis.<xref rid="B8-kjped-61-156" ref-type="bibr">8)</xref></p><p>In sepsis, the release of bacterial toxin triggers a series of events that stimulate intracellular pathways to produce inflammatory mediators. One of these mediators is ADM which has an important role in vascular tone regulation in infection and cardiovascular disease.<xref rid="B9-kjped-61-156" ref-type="bibr">9)</xref></p><p>ADM has a potent vasodilator property. Its stable midregional pro-hormone fragment, pro-ADM, is used as a biomarker of sepsis and cardiovascular diseases in adults.<xref rid="B10-kjped-61-156" ref-type="bibr">10)</xref> Many adult studies investigated the relationship between infection and pro-ADM. In a study of 101 adult patients, authors found a significant increase in pro-ADM levels in septic patients as compared with healthy controls and critically ill patients without infections.<xref rid="B6-kjped-61-156" ref-type="bibr">6)</xref> Moreover, Angeletti et al.<xref rid="B11-kjped-61-156" ref-type="bibr">11)</xref> investigated the pro-ADM levels of adult patients with bacterial infection, and they showed that pro-ADM levels are significantly increased in patients suffering from localized bacterial infections.</p><p>The results of the present study showed that serum pro-ADM levels were significantly higher among septic infants compared with healthy ones. This finding comes in agreement with previous studies suggesting increased levels of pro-ADM in neonates with bacterial infection.<xref rid="B12-kjped-61-156" ref-type="bibr">12</xref><xref rid="B13-kjped-61-156" ref-type="bibr">13)</xref></p><p>Our study revealed that nonsurviving patients had significantly elevated pro-ADM levels when compared to the survivors (15.08&#xB1;0.28 nmol/L vs. 14.21&#xB1;0.73 nmol/L, <italic>P</italic>=0.001). This observation is similar to that of a recent study by Abd Elmouttaleb et al.<xref rid="B14-kjped-61-156" ref-type="bibr">14)</xref>, in which pro-ADM levels were significantly higher in nonsurviving septic neonates. Wang and Kang<xref rid="B15-kjped-61-156" ref-type="bibr">15)</xref> studied the value of pro-ADM as a prognostic marker in septic adults. Their study revealed that pro-ADM levels were significantly elevated in nonsurvivors, and that pro-ADM was valuable marker for predicting sepsis severity and outcome.</p><p>We used the ROC curve analysis to select the best cutoff value for pro-ADM. The ideal cutoff value for pro-ADM is the level capable to discover nearly all true cases (high sensitivity) with a little probability of false positives (high specificity). For neonatal sepsis, it is more valuable to have the highest level of sensitivity than the highest level of specificity.<xref rid="B16-kjped-61-156" ref-type="bibr">16)</xref></p><p>In our study, pro-ADM (using a cutoff value of 4.3 nmol/L) had a sensitivity of 93.3% and specificity of 86.7% with a positive predictive value of 93.3 % and negative predictive value of 86.6%. In a study using pro-ADM to discern sepsis in neonates, Oncel et al.<xref rid="B12-kjped-61-156" ref-type="bibr">12)</xref> reported sensitivity comparable with ours (93.5% for a cutoff value 3.9 nmol/L) but higher specificity (100%). Another study by Cao et al.<xref rid="B13-kjped-61-156" ref-type="bibr">13)</xref> is similar to ours, but their sensitivity is much lower (51.53%). However, the number of patients with culture-proven sepsis in the above-mentioned studies is smaller than in our study, and none of them evaluate pro-ADM as prognostic marker.</p><p>Debiane et al.<xref rid="B17-kjped-61-156" ref-type="bibr">17)</xref> evaluated pro-ADM as a marker of sepsis in adult patients with malignancy. They reported 67% sensitivity and 68% specificity for pro-ADM at a cutoff value 2.2 nmol/L.</p><p>We found a positive correlation between pro-ADM and C-reactive protein (<italic>r</italic>=0.662, <italic>P</italic>&lt;0.001). Similar finding has been reported in previous study.<xref rid="B12-kjped-61-156" ref-type="bibr">12)</xref> On the other hand, pro-ADM were negatively correlated with platelets count (<italic>r</italic>=&#x2212;0.714, <italic>P</italic>&lt;0.001) in our patients. Comparable finding has been reported in previous adult study.<xref rid="B18-kjped-61-156" ref-type="bibr">18)</xref></p><p>The main strength of this study is that we have included only patients with blood culture-proven sepsis.</p><p>Our study has some limitations. First, the sample size was relatively small. Second, no comparison was made between pro-ADM and other inflammatory markers (as erythrocyte sedimentation rate and procalcitonin). Third, single measurement of pro-ADM levels was done, so serial measurement of pro-ADM might be more useful.</p><p>In conclusion, our study highlights the role of pro-ADM in neonatal sepsis. Pro-ADM may be considered a reliable marker for neonatal sepsis that could help in identifying septic neonates. A value higher than 4.3 nmol/L should raise the suspicion of sepsis. High pro-ADM concentration was associated with mortality and could be an early indicator of disease outcome.</p></sec></body><back><ack><title>Acknowledgments</title><p>We gratefully acknowledge the valuable cooperation provided by our colleagues in the NICU, Beni Suef University Hospital.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><ref id="B1-kjped-61-156"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title>Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis</article-title><source>Ital J Pediatr</source><year>2016</year><volume>42</volume><fpage>57</fpage><pub-id pub-id-type="pmid">27268050</pub-id></element-citation></ref><ref id="B2-kjped-61-156"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cernada</surname><given-names>M</given-names></name><name><surname>Serna</surname><given-names>E</given-names></name><name><surname>Bauerl</surname><given-names>C</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>P&#xE9;rez-Mart&#xED;nez</surname><given-names>G</given-names></name><name><surname>Vento</surname><given-names>M</given-names></name></person-group><article-title>Genome-wide expression profiles in very low birth weight infants with neonatal sepsis</article-title><source>Pediatrics</source><year>2014</year><volume>133</volume><fpage>e1203</fpage><lpage>e1211</lpage><pub-id pub-id-type="pmid">24709930</pub-id></element-citation></ref><ref id="B3-kjped-61-156"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delanghe</surname><given-names>JR</given-names></name><name><surname>Speeckaert</surname><given-names>MM</given-names></name></person-group><article-title>Translational research and biomarkers in neonatal sepsis</article-title><source>Clin Chim Acta</source><year>2015</year><volume>451</volume><issue>Pt A</issue><fpage>46</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">25661089</pub-id></element-citation></ref><ref id="B4-kjped-61-156"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>BM</given-names></name><name><surname>Eslick</surname><given-names>GD</given-names></name><name><surname>Craig</surname><given-names>JC</given-names></name><name><surname>McLean</surname><given-names>AS</given-names></name></person-group><article-title>Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis</article-title><source>Lancet Infect Dis</source><year>2007</year><volume>7</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">17317602</pub-id></element-citation></ref><ref id="B5-kjped-61-156"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgenthaler</surname><given-names>NG</given-names></name><name><surname>Struck</surname><given-names>J</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Bergmann</surname><given-names>A</given-names></name></person-group><article-title>Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay</article-title><source>Clin Chem</source><year>2005</year><volume>51</volume><fpage>1823</fpage><lpage>1829</lpage><pub-id pub-id-type="pmid">16099941</pub-id></element-citation></ref><ref id="B6-kjped-61-156"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ-Crain</surname><given-names>M</given-names></name><name><surname>Morgenthaler</surname><given-names>NG</given-names></name><name><surname>Struck</surname><given-names>J</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name><name><surname>Bergmann</surname><given-names>A</given-names></name><name><surname>M&#xFC;ller</surname><given-names>B</given-names></name></person-group><article-title>Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study</article-title><source>Crit Care</source><year>2005</year><volume>9</volume><fpage>R816</fpage><lpage>R824</lpage><pub-id pub-id-type="pmid">16356231</pub-id></element-citation></ref><ref id="B7-kjped-61-156"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahmey</surname><given-names>SS</given-names></name></person-group><article-title>Early-onset sepsis in a neonatal intensive care unit in Beni Suef, Egypt: bacterial isolates and antibiotic resistance pattern</article-title><source>Korean J Pediatr</source><year>2013</year><volume>56</volume><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">24019843</pub-id></element-citation></ref><ref id="B8-kjped-61-156"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mussap</surname><given-names>M</given-names></name></person-group><article-title>Laboratory medicine in neonatal sepsis and inflammation</article-title><source>J Matern Fetal Neonatal Med</source><year>2012</year><volume>25</volume><issue>Suppl 4</issue><fpage>32</fpage><lpage>34</lpage></element-citation></ref><ref id="B9-kjped-61-156"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito</surname><given-names>J</given-names></name><name><surname>Luaces-Cubells</surname><given-names>C</given-names></name><name><surname>Mintegi</surname><given-names>S</given-names></name><name><surname>Astobiza</surname><given-names>E</given-names></name><name><surname>Martinez-Indart</surname><given-names>L</given-names></name><name><surname>Valls-Lafont</surname><given-names>A</given-names></name><etal/></person-group><article-title>Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source</article-title><source>Eur J Pediatr</source><year>2013</year><volume>172</volume><fpage>1441</fpage><lpage>1449</lpage><pub-id pub-id-type="pmid">23793138</pub-id></element-citation></ref><ref id="B10-kjped-61-156"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Admaty</surname><given-names>D</given-names></name><name><surname>Benzing</surname><given-names>J</given-names></name><name><surname>Burkhardt</surname><given-names>T</given-names></name><name><surname>Lapaire</surname><given-names>O</given-names></name><name><surname>Hegi</surname><given-names>L</given-names></name><name><surname>Szinnai</surname><given-names>G</given-names></name><etal/></person-group><article-title>Plasma midregional proadrenomedullin in newborn infants: impact of prematurity and perinatal infection</article-title><source>Pediatr Res</source><year>2012</year><volume>72</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">22447319</pub-id></element-citation></ref><ref id="B11-kjped-61-156"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeletti</surname><given-names>S</given-names></name><name><surname>Spoto</surname><given-names>S</given-names></name><name><surname>Fogolari</surname><given-names>M</given-names></name><name><surname>Cortigiani</surname><given-names>M</given-names></name><name><surname>Fioravanti</surname><given-names>M</given-names></name><name><surname>De Florio</surname><given-names>L</given-names></name><etal/></person-group><article-title>Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections</article-title><source>APMIS</source><year>2015</year><volume>123</volume><fpage>740</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">26058482</pub-id></element-citation></ref><ref id="B12-kjped-61-156"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oncel</surname><given-names>MY</given-names></name><name><surname>Dilmen</surname><given-names>U</given-names></name><name><surname>Erdeve</surname><given-names>O</given-names></name><name><surname>Ozdemir</surname><given-names>R</given-names></name><name><surname>Calisici</surname><given-names>E</given-names></name><name><surname>Yurttutan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Proadrenomedullin as a prognostic marker in neonatal sepsis</article-title><source>Pediatr Res</source><year>2012</year><volume>72</volume><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">22885414</pub-id></element-citation></ref><ref id="B13-kjped-61-156"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection</article-title><source>Acta Paediatr</source><year>2012</year><volume>101</volume><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">22053979</pub-id></element-citation></ref><ref id="B14-kjped-61-156"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd Elmouttaleb</surname><given-names>AT</given-names></name><name><surname>Aly</surname><given-names>HA</given-names></name><name><surname>Bayomy</surname><given-names>EM</given-names></name><name><surname>Abdelhamed</surname><given-names>MR</given-names></name><name><surname>Esmael</surname><given-names>NF</given-names></name></person-group><article-title>Plasma procalcitonin and proadrenomedullin concentrations as predictive markers for early onset neonatal sepsis</article-title><source>Am J Biochem</source><year>2016</year><volume>6</volume><fpage>6</fpage><lpage>15</lpage></element-citation></ref><ref id="B15-kjped-61-156"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RL</given-names></name><name><surname>Kang</surname><given-names>FX</given-names></name></person-group><article-title>Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin</article-title><source>Chin J Traumatol</source><year>2010</year><volume>13</volume><fpage>152</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">20515592</pub-id></element-citation></ref><ref id="B16-kjped-61-156"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>RC</given-names></name><name><surname>Procianoy</surname><given-names>RS</given-names></name></person-group><article-title>Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis</article-title><source>Acta Paediatr</source><year>1999</year><volume>88</volume><fpage>647</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">10419250</pub-id></element-citation></ref><ref id="B17-kjped-61-156"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debiane</surname><given-names>L</given-names></name><name><surname>Hachem</surname><given-names>RY</given-names></name><name><surname>Al Wohoush</surname><given-names>I</given-names></name><name><surname>Shomali</surname><given-names>W</given-names></name><name><surname>Bahu</surname><given-names>RR</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer<sup>*</sup></article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><fpage>2500</fpage><lpage>2507</lpage><pub-id pub-id-type="pmid">25083975</pub-id></element-citation></ref><ref id="B18-kjped-61-156"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeletti</surname><given-names>S</given-names></name><name><surname>Battistoni</surname><given-names>F</given-names></name><name><surname>Fioravanti</surname><given-names>M</given-names></name><name><surname>Bernardini</surname><given-names>S</given-names></name><name><surname>Dicuonzo</surname><given-names>G</given-names></name></person-group><article-title>Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis</article-title><source>Clin Chem Lab Med</source><year>2013</year><volume>51</volume><fpage>1059</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">23072859</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1-kjped-61-156" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Proadrenomedullin (Pro-ADM) levels in survivors and nonsurvivors. Pro-ADM levels were significantly higher in nonsurvivors (15.08&#xB1;0.27 nmol/L) than in survivors (14.21&#xB1;0.72 nmol/L). <italic>P</italic>=0.001.</title></caption><graphic xlink:href="kjped-61-156-g001"/></fig><fig id="F2-kjped-61-156" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Receiver operating characteristic curve for proadrenomedullin (pro-ADM) at a cutoff value of 4.3 nmol/L. The area under the curve was 0.923 (95% confidence interval, 0.85&#x2013;0.97). The sensitivity, specificity, positive predictive value, and negative predictive value were 93.3%, 86.7%, 93.3%, and 86.6%, respectively.</title></caption><graphic xlink:href="kjped-61-156-g002"/></fig><table-wrap id="T1-kjped-61-156" orientation="portrait" position="float"><label>Table 1</label><caption><title>Demographic and laboratory data of case and control groups</title></caption><alternatives><graphic xlink:href="kjped-61-156-i001"/><table frame="hsides" rules="rows"><col width="34.27%" span="1"/><col width="23.39%" span="1"/><col width="25.4%" span="1"/><col width="16.94%" span="1"/><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Sepsis (n=60)</th><th valign="middle" align="center" rowspan="1" colspan="1">Control (n=30)</th><th valign="middle" align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gestational age (wk)</td><td valign="top" align="center" rowspan="1" colspan="1">33.2&#xB1;2.3</td><td valign="top" align="center" rowspan="1" colspan="1">35.6&#xB1;2.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">Weight (g)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">2,133&#xB1;788</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">2,676&#xB1;801</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex, male:female</td><td valign="top" align="center" rowspan="1" colspan="1">26:34</td><td valign="top" align="center" rowspan="1" colspan="1">14:16</td><td valign="top" align="center" rowspan="1" colspan="1">0.54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">CS:NVD</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">48:12</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">18:12</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.26</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hb (gm/dL)</td><td valign="top" align="center" rowspan="1" colspan="1">9.61&#xB1;2.95</td><td valign="top" align="center" rowspan="1" colspan="1">14.13&#xB1;1.41</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">Platelets (&#xD7;10<sup>3</sup>/&#xB5;L)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">112&#xB1;34</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">334&#xB1;67</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">WBC (&#xD7;10<sup>3</sup>/&#xB5;L)</td><td valign="top" align="center" rowspan="1" colspan="1">7.2&#xB1;3.2</td><td valign="top" align="center" rowspan="1" colspan="1">8.7&#xB1;1.03</td><td valign="top" align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">CRP (mg/dL)</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">54&#xB1;6.41</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">1.8&#xB1;0.27</td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pro-ADM (nmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">14.39&#xB1;0.75</td><td valign="top" align="center" rowspan="1" colspan="1">3.12&#xB1;0.23</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Values are presented as mean&#xB1;standard deviation</p><p>CS, cesarean section; NVD, normal vaginal delivery; Hb, hemoglobin; WBC, white blood cells; CRP, C-reactive protein; Pro-ADM, proadrenomedullin.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2-kjped-61-156" orientation="portrait" position="float"><label>Table 2</label><caption><title>Distribution of pathogens isolated from neonates with sepsis</title></caption><alternatives><graphic xlink:href="kjped-61-156-i002"/><table frame="hsides" rules="rows"><col width="78.49%" span="1"/><col width="21.51%" span="1"/><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Organisms</th><th valign="middle" align="center" rowspan="1" colspan="1">No. (%)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Klebsiella pneumoniae</italic></td><td valign="top" align="center" rowspan="1" colspan="1">21 (35)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)"><italic>Escherichia coli</italic></td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">15 (25)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Enterobacter cloacae</italic></td><td valign="top" align="center" rowspan="1" colspan="1">9 (15)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)"><italic>Acinetobacter baumannii</italic></td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">7 (11.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic></td><td valign="top" align="center" rowspan="1" colspan="1">4 (6.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)"><italic>Coagulase negative staphylococci</italic></td><td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">4 (6.7)</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="T3-kjped-61-156" orientation="portrait" position="float"><label>Table 3</label><caption><title>Correlation between pro-ADM and other parameters in the sepsis group</title></caption><alternatives><graphic xlink:href="kjped-61-156-i003"/><table frame="hsides" rules="rows"><col width="35.82%" span="1"/><col width="46.77%" span="1"/><col width="17.41%" span="1"/><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Variable</th><th valign="middle" align="center" rowspan="1" colspan="1">Pearson correlation (<italic>r</italic>)</th><th valign="middle" align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Weight</td><td valign="top" align="right" rowspan="1" colspan="1">0.369</td><td valign="top" align="right" rowspan="1" colspan="1">0.013</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">Gestational age</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">&#x2212;0.021</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.893</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hemoglobin</td><td valign="top" align="right" rowspan="1" colspan="1">&#x2212;0.620</td><td valign="top" align="right" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">White blood cells</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">&#x2212;0.262</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.820</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Platelets</td><td valign="top" align="right" rowspan="1" colspan="1">&#x2212;0.714</td><td valign="top" align="right" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">CRP</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">0.662</td><td valign="top" align="right" rowspan="1" colspan="1" style="background-color:rgb(241,242,242)">&lt;0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Pro-ADM, proadrenomedullin; CRP, C-reactive protein.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
